Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.50 USD
Change Today +0.05 / 3.45%
Volume 200.0
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Nevan C. Elam J.D.

Chairman, Chief Executive Officer and President, AntriaBio, Inc.
AgeTotal Calculated CompensationThis person is connected to 23 board members in 4 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Nevan C. Elam, JD, has been the Chief Executive Officer and President of AntriaBio, Inc., since January 31, 2013. Mr. Elam serves as Managing Director of Konus Advisory Group. He serves as Chief Executive Officer and President of AeroSurgical Ltd. He served as Head of the Pulmonary Business Unit and Senior Vice President of Nektar Therapeutics from April 2, 2007 to December 31, 2008. He served as General Counsel and Secretary of Nektar Therapeutics from January 17, ...

Read Full Background

Corporate Headquarters*

890 Santa Cruz Avenue
Menlo Park, California 94025

United States

Phone: 303-222-2128
Fax: --

Board Members Memberships*

Chief Executive Officer, President and Director
Chairman, Chief Executive Officer and President


Howard University
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$361,235

Stock Options*

Exercisable Options513,773
Total Number of Options1,933,334

Total Compensation*

Total Annual Cash Compensation$361,235
Total Short Term Compensation$361,235
Total Calculated Compensation$918,998
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ANTB:US $1.50 USD +0.05


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANTRIABIO INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at